These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31856446)

  • 21. Biomarker Panel for Chronic Graft-Versus-Host Disease.
    Yu J; Storer BE; Kushekhar K; Abu Zaid M; Zhang Q; Gafken PR; Ogata Y; Martin PJ; Flowers ME; Hansen JA; Arora M; Cutler C; Jagasia M; Pidala J; Hamilton BK; Chen GL; Pusic I; Lee SJ; Paczesny S
    J Clin Oncol; 2016 Aug; 34(22):2583-90. PubMed ID: 27217465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia.
    Lv M; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X; Mo X
    Front Med; 2019 Dec; 13(6):667-679. PubMed ID: 31512033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.
    Weissinger EM; Human C; Metzger J; Hambach L; Wolf D; Greinix HT; Dickinson AM; Mullen W; Jonigk D; Kuzmina Z; Kreipe H; Schweier P; Böhm O; Türüchanow I; Ihlenburg-Schwarz D; Raad J; Durban A; Schiemann M; Könecke C; Diedrich H; Holler E; Beutel G; Krauter J; Ganser A; Stadler M
    Leukemia; 2017 Mar; 31(3):654-662. PubMed ID: 27677743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Yu WJ; Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):912-920. PubMed ID: 30485788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
    Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
    Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
    Saillard C; Crocchiolo R; Furst S; El-Cheikh J; Castagna L; Signori A; Oudin C; Faucher C; Lemarie C; Chabannon C; Granata A; Blaise D
    Leuk Lymphoma; 2014 May; 55(5):1106-12. PubMed ID: 23822538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.
    Lai P; Weng J; Lu Z; Guo R; Luo C; Wu S; Ling W; Geng S; Du X
    DNA Cell Biol; 2011 Dec; 30(12):1019-25. PubMed ID: 21682596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning.
    Poloni A; Sartini D; Emanuelli M; Trappolini S; Mancini S; Pozzi V; Costantini B; Serrani F; Berardinelli E; Renzi E; Olivieri A; Leoni P
    Cytokine; 2011 Mar; 53(3):376-83. PubMed ID: 21211989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Metabolomics in Allogeneic Hematopoietic Cell Transplantation Recipients Discordant for Chronic Graft-versus-Host Disease.
    Lynch Kelly D; Farhadfar N; Starkweather A; Garrett TJ; Yao Y; Wingard JR; Mahmud I; Menzies V; Patel P; Alabasi KM; Lyon D
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1803-1810. PubMed ID: 32592859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
    Goklemez S; Im AP; Cao L; Pirsl F; Steinberg SM; Curtis LM; Mitchell SA; Cowen EW; Baruffaldi J; Rose J; Mays J; Ostojic A; Holtzman NG; Hakim FT; Pavletic SZ
    Am J Hematol; 2020 Apr; 95(4):387-394. PubMed ID: 31903638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study.
    Nasilowska-Adamska B; Czyz A; Markiewicz M; Rzepecki P; Piatkowska-Jakubas B; Paluszewska M; Dzierzak-Mietla M; Solarska I; Borg K; Prochorec-Sobieszek M; Szydlo R; Lewandowski K; Skotnicki A; Jedrzejczak WW; Kyrcz-Krzemien S; Komarnicki M; Warzocha K
    Eur J Haematol; 2016 Mar; 96(3):236-44. PubMed ID: 25912052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.
    Hillhouse EE; Thiant S; Moutuou MM; Lombard-Vadnais F; Parat R; Delisle JS; Ahmad I; Roy DC; Guimond M; Roy J; Lesage S
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):19-25. PubMed ID: 30244108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
    Urbano-Ispizua A; García-Conde J; Brunet S; Hernández F; Sanz G; Petit J; Bargay J; Figuera A; Rovira M; Solano C; Ojeda E; de la Rubia J; Rozman C
    Haematologica; 1997; 82(6):683-9. PubMed ID: 9499667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: A preliminary study.
    Łacina P; Crossland RE; Wielińska J; Czyż A; Szeremet A; Ussowicz M; Wróbel T; Dickinson AM; Bogunia-Kubik K
    Adv Clin Exp Med; 2023 May; 32(5):539-544. PubMed ID: 36398373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of Chronic Graft versus Host Disease -Review].
    Wang FY; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):286-290. PubMed ID: 28245418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease.
    Novitzky-Basso I; Schain F; Batyrbekova N; Webb T; Remberger M; Keating A; Mattsson J
    PLoS One; 2023; 18(3):e0282753. PubMed ID: 36893113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prophylaxis and treatment of chronic graft versus host disease].
    Huang K; Li Y; Huang SL; Fang JP; Zhou DH; Chen C
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):174-7. PubMed ID: 15833186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Increment of chemokine CXCL9/Mig in plasma correlated with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Ji LH; Ren HY; Shi YJ; Cen XN; Qiu ZX; Ou JP; Xu WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1200-3. PubMed ID: 17204194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
    Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
    Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
    Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
    J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.